LPL Financial LLC Grows Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

LPL Financial LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 3.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 444,567 shares of the company's stock after acquiring an additional 16,881 shares during the quarter. LPL Financial LLC owned 0.10% of GE HealthCare Technologies worth $34,756,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Cathy Pareto & Associates Inc. acquired a new stake in GE HealthCare Technologies in the 4th quarter valued at about $670,000. Principal Financial Group Inc. raised its holdings in GE HealthCare Technologies by 1.9% in the third quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after acquiring an additional 19,010 shares in the last quarter. Everence Capital Management Inc. lifted its stake in GE HealthCare Technologies by 118.2% in the fourth quarter. Everence Capital Management Inc. now owns 18,870 shares of the company's stock worth $1,475,000 after acquiring an additional 10,220 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in GE HealthCare Technologies by 9.7% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 145,996 shares of the company's stock worth $13,702,000 after acquiring an additional 12,908 shares in the last quarter. Finally, Apollon Wealth Management LLC increased its position in shares of GE HealthCare Technologies by 46.5% in the 4th quarter. Apollon Wealth Management LLC now owns 13,111 shares of the company's stock valued at $1,025,000 after purchasing an additional 4,160 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and increased their price objective for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have issued a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus target price of $98.75.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded up $0.70 during trading on Monday, reaching $80.71. The company's stock had a trading volume of 4,151,176 shares, compared to its average volume of 2,938,521. The business's fifty day moving average price is $86.70 and its 200-day moving average price is $85.86. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm has a market cap of $36.91 billion, a price-to-earnings ratio of 18.64, a P/E/G ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analysts' expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. GE HealthCare Technologies's payout ratio is currently 3.23%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.